Influenza Vaccine(Split Virion), Inactivated, Quadrivalent (Dalian Aleph Biomedical)

四价流感病毒裂解疫苗（大连雅立峰生物）

Report date: 2025/06/20 15:43:54

Base Information

Drug NameInfluenza Vaccine(Split Virion), Inactivated, Quadrivalent (Dalian Aleph Biomedical)
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, HumanCommon Cold
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2025/06/17
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDalian Aleph Biomedical Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDalian Aleph Biomedical Company Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, HumanCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A